SIGILON THERAPEUTICS, INC.

Inactive Instrument

Analyst Reco. Sigilon Therapeutics, Inc.

Equities

SGTX

US82657L2060

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Canaccord Genuity Adjusts Price Target on Sigilon Therapeutics to $30 From $6, Maintains Buy Rating	23-07-05	MT
Morgan Stanley Adjusts Price Target on Sigilon Therapeutics to $21 From $7, Maintains Equalweight Rating	23-06-30	MT
BTIG Downgrades Sigilon Therapeutics to Neutral From Buy	23-06-30	MT
Canaccord Genuity Initiates Coverage on Sigilon Therapeutics With Buy Rating, $6 Price Target	23-01-18	MT
Morgan Stanley Adjusts Sigilon Therapeutics Price Target to $2 From $4.50, Maintains Equalweight Rating	22-02-01	MT
Canaccord Genuity Adjusts Sigilon Therapeutics' Price Target to $7 From $12, Reiterates Buy Rating	21-12-23	MT
Barclays Adjusts Sigilon Therapeutics' Price Target to $7 From $16, Reiterates Overweight Rating	21-12-01	MT
Canaccord Genuity Further Cuts Sigilon Therapeutics' Price Target to $12 From $23, Keeps Buy Rating	21-11-30	MT
Jefferies Cuts Sigilon Therapeutics to Hold From Buy, Price Target to $4 From $15	21-11-30	MT
Morgan Stanley Adjusts Sigilon Therapeutics' Price Target to $4.50 From $9, Keeps Equalweight Rating	21-11-30	MT
Canaccord Genuity Adjusts Price Target on Sigilon Therapeutics to $23 From $43, Maintains Buy Rating	21-11-29	MT
BTIG Starts Sigilon Therapeutics at Buy With $14 Price Target	21-10-29	MT
SIGILON THERAPEUTICS : Canaccord Genuity Adjusts Sigilon Therapeutics PT to $43 From $62, Maintains Buy Rating	21-07-19	MT
SIGILON THERAPEUTICS : Morgan Stanley Adjusts Price Target on Sigilon Therapeutics to $9 From $45, Maintains Equal-Weight Rating	21-07-16	MT
SIGILON THERAPEUTICS : Barclays Starts Sigilon Therapeutics at Overweight With $48 Price Target	20-12-29	MT
SIGILON THERAPEUTICS : Jefferies Starts Sigilon Therapeutics at Buy With $60 Price Target	20-12-29	MT
SIGILON THERAPEUTICS : Morgan Stanley Initiates Coverage on Sigilon Therapeutics With Equal-Weight Rating, $45 Price Target	20-12-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer